Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Anandamide
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Berger C et al. | Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? | 2004 | J. Neurochem. | pmid:15009671 |
Price TJ et al. | Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. | 2004 | Br. J. Pharmacol. | pmid:15006899 |
Sun YX et al. | Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. | 2004 | Biochem. J. | pmid:14998370 |
Steffens M et al. | Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. | 2004 | Br. J. Pharmacol. | pmid:14993102 |
Costanzi M et al. | Effects of anandamide and morphine combinations on memory consolidation in cd1 mice: involvement of dopaminergic mechanisms. | 2004 | Neurobiol Learn Mem | pmid:14990234 |
Fernández-Solari J et al. | Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system. | 2004 | Proc. Natl. Acad. Sci. U.S.A. | pmid:14981261 |
Basta PV et al. | Preparation of monoclonal antibodies reactive to the endogenous small molecule, anandamide. | 2004 | J. Immunol. Methods | pmid:14980433 |
Guo J and Ikeda SR | Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. | 2004 | Mol. Pharmacol. | pmid:14978245 |
Ligresti A et al. | Further evidence for the existence of a specific process for the membrane transport of anandamide. | 2004 | Biochem. J. | pmid:14969584 |
Lin GC et al. | Gap junctional communication modulates agonist-induced calcium oscillations in transfected HeLa cells. | 2004 | J. Cell. Sci. | pmid:14762115 |
Matias I et al. | Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. | 2004 | J. Pharmacol. Exp. Ther. | pmid:14757851 |
Moezi L et al. | Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide. | 2004 | Eur. J. Pharmacol. | pmid:14751408 |
Dennedy MC et al. | Cannabinoids and the human uterus during pregnancy. | 2004 | Am. J. Obstet. Gynecol. | pmid:14749627 |
Murillo-Rodriguez E et al. | Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. | 2003 | Sleep | pmid:14746372 |
de Lago E et al. | In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. | 2004 | Eur. J. Pharmacol. | pmid:14744610 |
Weber A et al. | Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. | 2004 | J. Lipid Res. | pmid:14729864 |
Maccarrone M | Inhibition of anandamide hydrolysis: cells also know how to do it. | 2004 | Trends Mol Med | pmid:14720580 |
Akerman S et al. | Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. | 2004 | J. Pharmacol. Exp. Ther. | pmid:14718591 |
Ruiz-Llorente L et al. | Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. | 2004 | Br. J. Pharmacol. | pmid:14718261 |
Lees G and Dougalis A | Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro. | 2004 | Brain Res. | pmid:14715144 |
Devane WA et al. | Isolation and structure of a brain constituent that binds to the cannabinoid receptor. | 1992 | Science | pmid:1470919 |
Piomelli D | THC: moderation during implantation. | 2004 | Nat. Med. | pmid:14702623 |
Kasai HF et al. | Analyses of anandamide and endocannabinoid-like compounds using collision-induced dissociation in fast atom bombardment ionization-mass spectrometry and gas chromatography/chemical ionization-mass spectrometry. | 2003 | Anal Sci | pmid:14696920 |
Wenger T et al. | The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice. | 2003 | Neuroendocrinology | pmid:14688442 |
Motobe T et al. | Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome. | 2004 | Shock | pmid:14676677 |
Arizzi MN et al. | Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. | 2004 | Life Sci. | pmid:14672756 |
Nilsson O et al. | Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. | 2003 | Comp. Biochem. Physiol. C Toxicol. Pharmacol. | pmid:14659458 |
Wang H et al. | Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. | 2003 | Proc. Natl. Acad. Sci. U.S.A. | pmid:14645706 |
Zoratti C et al. | Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. | 2003 | Br. J. Pharmacol. | pmid:14645143 |
Jones S and Howl J | Cannabinoid receptor systems: therapeutic targets for tumour intervention. | 2003 | Expert Opin. Ther. Targets | pmid:14640910 |
Farquhar-Smith WP and Rice AS | A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. | 2003 | Anesthesiology | pmid:14639155 |
Kollarik M and Undem BJ | Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1-/- mice. | 2004 | J. Physiol. (Lond.) | pmid:14634201 |
Okamoto Y et al. | Molecular characterization of a phospholipase D generating anandamide and its congeners. | 2004 | J. Biol. Chem. | pmid:14634025 |
Sparling PB et al. | Exercise activates the endocannabinoid system. | 2003 | Neuroreport | pmid:14625449 |
Seagard JL et al. | Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition. | 2004 | Am. J. Physiol. Heart Circ. Physiol. | pmid:14615281 |
McAllister SD et al. | An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. | 2003 | J. Med. Chem. | pmid:14613317 |
Gaetani S et al. | Anandamide hydrolysis: a new target for anti-anxiety drugs? | 2003 | Trends Mol Med | pmid:14604824 |
Egashira N et al. | Anandamide inhibits the DOI-induced head-twitch response in mice. | 2004 | Psychopharmacology (Berl.) | pmid:14586538 |
Biswas KK et al. | Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis. | 2003 | Hepatology | pmid:14578855 |
Johnson RP et al. | System-specific O2 sensitivity of the tandem pore domain K+ channel TASK-1. | 2004 | Am. J. Physiol., Cell Physiol. | pmid:14576090 |
Chen N et al. | Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. | 2003 | Eur. J. Pharmacol. | pmid:14575792 |
Han B et al. | Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. | 2003 | J. Nat. Prod. | pmid:14575438 |
Steffens M et al. | Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex. | 2003 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:14566450 |
Maccarrone M et al. | Endocannabinoid degradation, endotoxic shock and inflammation. | 2002 | Curr Drug Targets Inflamm Allergy | pmid:14561206 |
Gurney AM et al. | Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. | 2003 | Circ. Res. | pmid:14551239 |
Marsicano G et al. | CB1 cannabinoid receptors and on-demand defense against excitotoxicity. | 2003 | Science | pmid:14526074 |
Mechoulam R and Lichtman AH | Neuroscience. Stout guards of the central nervous system. | 2003 | Science | pmid:14526067 |
Vandevoorde S et al. | Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase. | 2003 | J. Med. Chem. | pmid:14521402 |
Ross RA | Anandamide and vanilloid TRPV1 receptors. | 2003 | Br. J. Pharmacol. | pmid:14517174 |
Fowler CJ et al. | Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin. | 2003 | J Enzyme Inhib Med Chem | pmid:14506913 |